A polyluminescent cluster luminescent peptide material, its preparation method and application

By using organophosphorus initiators to catalyze the ring-opening polymerization of N-carboxylated intracyclic anhydride monomers, a fully photochromic cluster luminescent peptide material was prepared. This solved the problem of short-wavelength emission of peptide materials, achieving long-wavelength red light emission and high quantum yield, making it suitable for fields such as bioimaging.

CN123107072APending Publication Date: 2026-11-17ZHEJIANG UNIV
View PDF 0 Cites 0 Cited by

Patent Information

Application Number
CN202611442254.8
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2026-09-17
Publication Date
2026-11-17

AI Technical Summary

Technical Problem

Existing peptide materials mainly exhibit short-wavelength blue light emission, with limited means to adjust the emission color and efficiency. Furthermore, their application in bioimaging is limited by the background of autofluorescence in the blue-green light band and the limited light penetration into tissues.

Method used

An organic Lewis acid-base pair consisting of an organophosphorus initiator and triethylboron was used to catalyze the ring-opening polymerization of N-carboxylic acid anhydride monomers to prepare a full-color cluster luminescent peptide material. The conformation and molecular stacking behavior of the peptide chain segments were adjusted by the phosphorus end group to achieve full color coverage and high quantum yield.

Benefits of technology

It achieves full color coverage of the polypeptide material, with a maximum emission wavelength of 650 nm for red light emission and a high quantum yield of 21.4%, breaking through the emission bottleneck of traditional polypeptide materials and showing broad application prospects in bioimaging.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN123107072A_ABST
    Figure CN123107072A_ABST
Patent Text Reader

Abstract

This invention discloses a polypeptide material with a full-color cluster luminescence, exhibiting a maximum emission wavelength of 495–650 nm in solid state. Its general structural formula is shown in formula (Ⅰ), where R1, R2, and R3 are independently selected from phenyl or substituted phenyl groups; the substituents of the substituted phenyl groups are selected from fluorine, chlorine, bromine, trifluoromethyl, methoxy, dimethylamino, cyano, or aldehyde groups; R4 and R5 are independently selected from hydrogen, C1–C5 straight-chain or branched alkyl groups, but R4 and R5 are not simultaneously hydrogen; or, R4 and R5 are interconnected and together with their connected α-carbon atoms and nitrogen atoms form a five-membered nitrogen-containing ring. This invention achieves full-color coverage of intrinsic cluster luminescence in polypeptide materials for the first time; and for the first time, it achieves red light emission up to 650 nm and a high quantum yield of 21.4% for polysarcosine, breaking through the emission bottleneck of weak blue light at approximately 440 nm in traditional polypeptide materials. (Ⅰ)
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] This invention relates to the technical field of polymeric luminescent materials, specifically to a polyluminescent cluster luminescent peptide material, its preparation method, and its applications. Background Technology

[0002] Fluorescent materials play a crucial role in biomedical imaging, catalysis, sensing, and optoelectronic devices. While traditional organic fluorescent dyes, such as rhodamine and fluorescein, possess high quantum efficiency and full-spectrum emission capabilities, they typically rely on large π-conjugated chromophores, involve complex synthesis steps, have poor water solubility, and their hydrophobic conjugated frameworks may pose certain biocompatibility risks. Therefore, developing novel fluorescent materials that do not rely on traditional π-conjugated chromophores, have simple structures, and are suitable for aqueous environments is of great significance.

[0003] In recent years, clusteroluminescence (CL), as a novel luminescence mechanism independent of traditional π-conjugated chromophores, has attracted widespread attention. Clusteroluminescence is a phenomenon in which non-conjugated groups (such as amide, carbonyl, and ester groups) or heteroatoms (O, N, and S) emit light through spatial interactions and electronic coupling in an aggregated state. In 2013, Academician Tang Benzhong's team proposed the concept of "clusterization-triggered emission" (CTE), providing an important theoretical framework for explaining the anomalous luminescence phenomena of non-conjugated small molecules and polymers in an aggregated state.

[0004] In cluster luminescence systems, amide-rich peptides naturally possess the structural basis for cluster luminescence and have attracted widespread attention due to their simple structure, ease of modification, and good biocompatibility. Compared to existing cluster luminescent polyester materials, some peptide materials exhibit good water solubility and biocompatibility potential. Among them, polysarcosine and poly(N-ethylglycine) peptides have good water solubility; although the water solubility of other peptide materials containing alkyl side chains varies with the side chain structure, their hydrophilicity-hydrophobicity balance and aggregation behavior can still be regulated through polymer sequence structure. In particular, polysarcosine combines good water solubility, biocompatibility, and low non-specific protein adsorption tendency, exhibiting hydrophilicity and "stealth" properties similar to polyethylene glycol, and is considered one of the ideal alternatives to polyethylene glycol. Therefore, peptide materials, represented by polysarcosine, provide a good material basis for constructing novel luminescent materials that combine cluster luminescence performance, water solubility, and good biocompatibility.

[0005] However, existing peptide cluster luminescent materials mainly exhibit short-wavelength blue light emission, and the means to adjust their emission color and efficiency are relatively limited. Peptides prepared by traditional primary or secondary amine-initiated ring-opening polymerization of N-carboxylic acid anhydride monomers mostly exhibit intrinsic cluster luminescence concentrated in the blue light region around 440 nm, with typically low quantum yields. For example, the maximum emission of solid-state poly(γ-benzyl-L-glutamic acid) synthesized using n-hexylamine initiation is approximately 425 nm (Biomacromolecules 2024, 25, 1897–1905); the maximum emission wavelength of poly(γ-benzyl-L-glutamic acid), poly(L-glutamic acid), and sodium poly(L-glutamic acid) is approximately 440 nm (Cell Rep. Phys. Sci. 2022, 3, 100716). Other studies have shown that high-temperature polycondensation of polyalanine has a maximum emission wavelength of 445 nm and a quantum yield of 5.0%–8.0% (Polym. Chem. 2017, 8, 1722-1727). Due to the strong autofluorescence background in the blue-green light band of biological tissues and cells, and the limited penetration ability of short-wavelength light, the application of this type of peptide material with short emission wavelengths and limited luminescence efficiency is somewhat limited in applications such as multicolor cell imaging and deep tissue fluorescence imaging.

[0006] In 2024, Chu et al. reported a class of non-conjugated polyesters with full-color cluster luminescence properties (J. Am. Chem. Soc. 2024, 146, 10889–10898). This study used organophosphorus-initiated copolymerization of epoxides and cyclic anhydrides to prepare phosphine-terminated non-conjugated polyesters with emission wavelengths covering approximately 400–700 nm. The study showed that phosphine end groups can influence the local conformation of the polyester chain and promote the clustering of phosphine end groups and ester groups through spatial (n, π*) interactions, forming "phosphine ester clusters." Changing the type of organophosphorus can affect the conformation of the polyester chain, thereby regulating the luminescence color and quantum yield of the material. This study demonstrates that using phosphine end groups to regulate the local conformation and spatial electronic interactions of non-conjugated polymers is an effective way to achieve control over cluster luminescence color and efficiency. However, the aforementioned phosphine-terminated regulation strategy is currently mainly applied to polyester systems.

[0007] Currently, no polypeptides with full-color cluster luminescence properties and their synthesis strategies have been reported. Summary of the Invention

[0008] To address the aforementioned technical problems, this invention discloses a full-color cluster-luminescent peptide material, achieving for the first time full-color coverage of intrinsic cluster luminescence in peptide materials. It also achieved for the first time red light emission of polysarcosine up to 650 nm and a high quantum yield of 21.4%, breaking through the emission bottleneck of weak blue light of about 440 nm in traditional peptide materials, and has broad application prospects in fields such as bioimaging.

[0009] The specific technical solution is as follows:

[0010] In a first aspect, the present invention provides a polyluminescent peptide material with the following general structural formula (Ⅰ):

[0011] (I);

[0012] In the formula, R1, R2, and R3 are independently selected from phenyl or substituted phenyl groups;

[0013] In the substituted phenyl group, the substituent is selected from fluorine, chlorine, bromine, trifluoromethyl, methoxy, dimethylamino, cyano, or aldehyde; the substituent is located at the 2, 3, or 4 position of the benzene ring;

[0014] R4 and R5 are independently selected from hydrogen, C1-C5 straight-chain or branched alkyl groups, but R4 and R5 are not both hydrogen;

[0015] Alternatively, R4 and R5 are connected to each other and together with the α-carbon atom and nitrogen atom to which they are connected, they form a five-membered nitrogen-containing ring. The connecting group formed by the connection of R4 and R5 is —CH2—CH2—CH2— or —CH2—C(=O)—CH2—.

[0016] n is selected from natural numbers from 25 to 40, and m is selected from natural numbers from 1 to 5;

[0017] The all-color cluster luminescent peptide material has a maximum emission wavelength of 495–650 nm in solid state, specifically 495 nm, 500 nm, 510 nm, 520 nm, 530 nm, 540 nm, 550 nm, 560 nm, 570 nm, 580 nm, 590 nm, 600 nm, 610 nm, 620 nm, 630 nm, 640 nm, 650 nm or any value within the above range.

[0018] Preferably, the quantum yield of the all-color cluster luminescent peptide material ranges from <1.0% to 21.4%, specifically 21.4%, 20%, 19%, 18%, 17%, 15%, 13%, 11%, 10%, 9%, 8%, 7%, 6%, 5%, 4%, 3%, 2%, 1%, <1.0%, or any value within the above range.

[0019] Preferably, the all-color cluster luminescent peptide material has a number-average molecular weight of 800~3000 Da.

[0020] Preferred:

[0021] In the substituted phenyl group, the substituent is selected from fluorine, chlorine, bromine, methoxy, dimethylamino, cyano or aldehyde; more preferably, the substituent is selected from cyano.

[0022] Preferred:

[0023] R4 is selected from hydrogen, methyl, ethyl, —CH2—CH2—CH3, —CH(CH3)—CH3—CH(CH3)—CH2—CH3 or —CH2—CH(CH3)—CH3;

[0024] R5 is selected from hydrogen, methyl, ethyl, —CH2—CH2—CH3, or —CH2—CH2—CH2—CH2—CH3;

[0025] Alternatively, the linking group formed by the interconnection of R4 and R5 is —CH2—CH2—CH2— or —CH2—C(=O)—CH2—.

[0026] Further preferably, the all-color cluster luminescent peptide material has the following structural formulas (1) to (14):

[0027] (1);

[0028] (2);

[0029] (3);

[0030] (4);

[0031] (5);

[0032] (6);

[0033] (7);

[0034] (8);

[0035] (9);

[0036] (10);

[0037] (11);

[0038] (12);

[0039] (13);

[0040] (14).

[0041] The further optimized peptide materials all exhibit a significant red shift in maximum emission wavelength compared to peptide materials prepared by conventional processes, with the longest reaching 650 nm red light emission, achieving... The full-color cluster emits light.

[0042] Secondly, the present invention provides a method for preparing the aforementioned all-color cluster luminescent peptide material, comprising:

[0043] The all-color cluster luminescent peptide material was prepared by using an organic Lewis acid-base pair composed of a phosphine initiator and triethylboron, and using propylene oxide as a co-initiator to catalyze the ring-opening polymerization of N-carboxylated intracyclic anhydride monomers.

[0044] The phosphine initiator is selected from triphenylphosphine and / or triphenylphosphine derivatives;

[0045] The N-carboxyl ring anhydride monomer has the following general structural formula (II):

[0046] (II);

[0047] In formula (II), R4 and R5 are independently selected from hydrogen, C1-C5 straight-chain or branched alkyl groups, but R4 and R5 are not both hydrogen;

[0048] Alternatively, R4 and R5 can be linked together to form a five-membered nitrogen-containing ring with the α-carbon atom and nitrogen atom to which they are linked. The linking group formed by the linking of R4 and R5 is —CH2—CH2—CH2— or —CH2—C(=O)—CH2—.

[0049] Unlike polyesters, peptide molecules have a high density of regularly arranged amide bonds. Their aggregation behavior is mainly influenced by the spatial interactions between amide bonds and end groups, the molecular chain conformation, and the intermolecular stacking mode. In non-conjugated cluster luminescent systems, the spatial proximity of these polar groups in the aggregated state may form local electronic coupling, thereby affecting the excited state energy levels and radiative transition processes.

[0050] Therefore, introducing organophosphine end groups with tunable electronic properties and aryl-substituted structures into peptide systems is not a simple replacement of existing phosphine-terminated polyester systems. The electronic properties, steric hindrance, and polarity of phosphine end groups influencing the local conformation and molecular packing of peptide segments have not yet been reported. Mechanistically, the repeating amide groups in the peptide backbone can form spatial electronic coupling structures with phosphine end groups that are completely different from those in polyester systems. Thus, research into the synergistic effects and regulation between organophosphine structures, peptide segment structures, and aggregate conformations offers the potential to develop new pathways for controlling the cluster emission wavelength and luminescence efficiency of peptides.

[0051] This invention employs an organophosphorus and triethylboron-based Lewis acid-base catalytic system to catalyze the ring-opening polymerization of N-carboxylated intracyclic anhydride monomers under the synergistic initiation of propylene oxide. By modifying the substituents on the aryl group of the organophosphorus, the electronic properties and steric effects of the phosphine terminal group can be adjusted. Furthermore, altering the substituent structures of the α-carbon and nitrogen atoms of the N-carboxylated intracyclic anhydride monomer can change the conformation of the polypeptide chain segments and their intermolecular stacking behavior. These synergistic changes in structural factors provide a new approach to regulating the luminescence properties of aggregated polypeptides, potentially extending the luminescence of polypeptide clusters from the traditional short-wavelength region to the long-wavelength region. Guided by this approach, this invention successfully synthesized a novel polypeptide material with full-color cluster luminescence properties through extensive experimental research.

[0052] Preferably, the phosphine initiator is selected from one or more of triphenylphosphine, tris(2-fluorophenyl)phosphine, tris(3-fluorophenyl)phosphine, tris(4-fluorophenyl)phosphine, tris(3-chlorophenyl)phosphine, tris(4-chlorophenyl)phosphine, tris(4-bromophenyl)phosphine, tris(4-trifluoromethylphenyl)phosphine, tris(2-methoxyphenyl)phosphine, tris(3-methoxyphenyl)phosphine, tris(4-methoxyphenyl)phosphine, (4-dimethylamino)phenyldiphenylphosphine, 2-(diphenylphosphine)benzonitrile, 3-(diphenylphosphine)benzonitrile, 4-(diphenylphosphine)benzonitrile, 2-(diphenylphosphine)benzaldehyde, 3-(diphenylphosphine)benzaldehyde, and 4-(diphenylphosphine)benzaldehyde;

[0053] Preferably, the N-carboxycyclic anhydride monomer is selected from sarcosine-N-carboxycyclic anhydride, N-ethyl-glycine-N-carboxycyclic anhydride, N-propyl-glycine-N-carboxycyclic anhydride, N-pentyl-glycine-N-carboxycyclic anhydride, L-proline-N-carboxycyclic anhydride, 4-oxo-L-proline-N-carboxycyclic anhydride, L-alanine-N-carboxycyclic anhydride, L-valine-N-carboxycyclic anhydride, and L-leucine-N-carboxycyclic anhydride. One or more of the following: N-carboxycyclic anhydride, L-isoleucine-N-carboxycyclic anhydride, N-methyl-L-alanine-N-carboxycyclic anhydride, N-methyl-L-2-aminobutyric acid-N-carboxycyclic anhydride, N-methyl-L-2-aminovaleric acid-N-carboxycyclic anhydride, N-methyl-L-valine-N-carboxycyclic anhydride, N-methyl-L-leucine-N-carboxycyclic anhydride, and N-methyl-L-isoleucine-N-carboxycyclic anhydride.

[0054] Further optimization:

[0055] The phosphine initiator is selected from one or more of 2-(diphenylphosphine)benzonitrile, 3-(diphenylphosphine)benzonitrile, 4-(diphenylphosphine)benzonitrile, 2-(diphenylphosphine)benzaldehyde, 3-(diphenylphosphine)benzaldehyde, and 4-(diphenylphosphine)benzaldehyde;

[0056] The N-carboxycyclic anhydride monomer is selected from one or more of the following: sarcosine-N-carboxycyclic anhydride, N-ethyl-glycine-N-carboxycyclic anhydride, N-propyl-glycine-N-carboxycyclic anhydride, N-pentyl-glycine-N-carboxycyclic anhydride, L-proline-N-carboxycyclic anhydride, 4-oxo-L-proline-N-carboxycyclic anhydride, N-methyl-L-alanine-N-carboxycyclic anhydride, N-methyl-L-2-aminobutyric acid-N-carboxycyclic anhydride, N-methyl-L-2-aminovaleric acid-N-carboxycyclic anhydride, N-methyl-L-valine-N-carboxycyclic anhydride, N-methyl-L-leucine-N-carboxycyclic anhydride, and N-methyl-L-isoleucine-N-carboxycyclic anhydride.

[0057] The polypeptide prepared by using the above-mentioned further preferred phosphine initiator and N-carboxylic acid anhydride monomer has a longer maximum emission wavelength.

[0058] Better:

[0059] The phosphine initiator is selected from 2-(diphenylphosphine)benzonitrile;

[0060] The N-carboxycyclic anhydride monomer is selected from one or more of sarcosine-N-carboxycyclic anhydride, N-ethyl-glycine-N-carboxycyclic anhydride, and L-proline-N-carboxycyclic anhydride.

[0061] The peptides prepared using the preferred phosphine initiator and N-carboxylic acid anhydride monomer all have a maximum solid-state emission wavelength of not less than 640 nm, emit strong red light, and have a quantum yield of not less than 15%.

[0062] Among them, sarcosine-N-carboxycyclic anhydride and N-ethyl-glycine-N-carboxycyclic anhydride both have excellent water solubility and are expected to be widely used in cell bioimaging and other biomedical applications.

[0063] Preferably, the molar ratio of phosphine initiator to triethylboron is 1:(1~3); specifically, it can be 1:1, 1:1.5, 1:2, 1:2.5, 1:3 or any ratio within the above range; more preferably, it is 1:1.

[0064] Preferably, the molar ratio of the phosphine initiator to the N-carboxyl anhydride monomer is 1:(20~40); specifically, it can be 1:20, 1:21, 1:22, 1:23, 1:25, 1:28, 1:30, 1:32, 1:35, 1:38, 1:40 or any ratio within the above range; more preferably, it is 1:40.

[0065] Preferably, the ring-opening polymerization is carried out at a temperature of 60~80℃, specifically 60℃, 62℃, 65℃, 68℃, 70℃, 72℃, 75℃, 78℃, 80℃ or any value within the above range; more preferably 60℃.

[0066] Preferably, the time for the ring-opening polymer is 12 to 24 hours, specifically 12 hours, 13 hours, 14 hours, 15 hours, 18 hours, 20 hours, 22 hours, 24 hours or any value within the above range.

[0067] In this invention, there are no special requirements for the amount of propylene oxide used. Preferably, the molar ratio of phosphine initiator to propylene oxide is 1:(10~50).

[0068] Thirdly, the present invention also provides the application of the aforementioned all-color cluster luminescent peptide material in the preparation of luminescent materials, fluorescent labeling materials, and fluorescent probes.

[0069] Fourthly, the present invention also provides the application of the aforementioned all-color cluster luminescent peptide material in bioimaging.

[0070] Compared with the prior art, the present invention has the following beneficial effects:

[0071] This invention discloses for the first time the full color coverage of intrinsic cluster luminescence in peptide materials. For the first time, polysarcosine has achieved red light emission up to 650 nm and a high quantum yield of 21.4%, significantly breaking through the emission bottleneck of weak blue light of about 440 nm in traditional peptide materials. In particular, polysarcosine and poly(N-ethylglycine), which have excellent water solubility, have a maximum emission wavelength of up to 650 nm and a high quantum yield, and are expected to be widely used in biomedical applications such as cell bioimaging.

[0072] This invention is the first to systematically apply an organic Lewis acid-base pair catalytic system to the synthesis of peptides. The method is simple to operate, has mild conditions, and the phosphine initiator is mainly a commercially available product, so there is no need to synthesize it yourself. It has good practicality and scalability.

[0073] The synthesis process disclosed in this invention allows for a wide range of systematic control over the emission wavelength (495–650 nm) and quantum yield (<1.0%–21.4%) of peptide clusters by changing the substituent structure of the phosphine initiator and the types of anhydride monomers within the N-carboxyl ring. Furthermore, this synthesis method is highly scalable: the structure of the phosphine initiator is highly adjustable (a wide variety of commercially available initiators can be selected based on different substituents on the benzene ring); the types of anhydride monomers within the N-carboxyl ring are abundant (diverse substituents can be modified at nitrogen atoms or methylene sites), enabling the construction of a more diverse library of luminescent peptide cluster materials. Attached Figure Description

[0074] Figure 1 Preparation of polypeptides for Comparative Example 1 1 H-NMR spectrum;

[0075] Figure 2 Fluorescence emission spectra and structural formulas of the polypeptide prepared for Comparative Example 1 under different excitation wavelengths and luminescence photographs under 360nm ultraviolet light excitation;

[0076] Figure 3 Preparation of polypeptides for Example 1 1 H-NMR spectrum;

[0077] Figure 4 The mass spectrum of the polypeptide prepared in Example 1;

[0078] Figure 5 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 1 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0079] Figure 6 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 2 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0080] Figure 7 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 3 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0081] Figure 8 The fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 4 under different excitation wavelengths and the luminescence photographs under 360nm ultraviolet light excitation;

[0082] Figure 9 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 5 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0083] Figure 10 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 6 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0084] Figure 11 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 7 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0085] Figure 12 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 8 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0086] Figure 13 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 9 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0087] Figure 14 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 10 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0088] Figure 15 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 11 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0089] Figure 16 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 12 under different excitation wavelengths, and luminescence photographs under 360nm ultraviolet light excitation;

[0090] Figure 17 Fluorescence emission spectra and structural formulas of the polypeptide prepared in Example 13 under different excitation wavelengths and luminescence photographs under 360nm ultraviolet light excitation;

[0091] Figure 18 The fluorescence emission spectra and structural formula of the polypeptide prepared in Example 14 under different excitation wavelengths and the luminescence photograph under 360nm ultraviolet light excitation are shown. Detailed Implementation

[0092] To make the objectives, technical solutions, and effects of this invention clearer and more explicit, the invention will be further described in detail below with reference to embodiments and accompanying drawings. However, it should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.

[0093] In this invention, the optimal excitation wavelength (λ) for the products prepared in each embodiment and comparative example is specified. ex Maximum emission wavelength (λ) em Both the quantum yield (QY) and solid quantum yield (QY) data were determined using transient / steady-state fluorescence spectroscopy.

[0094] Comparative Example 1

[0095] Before the polymerization reaction, a 10 mL thick-walled pressure-resistant tube was dried at 110 °C for 4 hours to remove moisture and then cooled to room temperature in a glove box. Sarcosine-N-carboxycyclic anhydride (138 mg, 1.20 mmol), n-hexylamine (4 μL, 0.03 mmol), and anhydrous acetonitrile (0.3 mL) were added sequentially to the tube. The reaction tube was sealed and reacted at autogenous pressure at room temperature (where the initiator is sufficient to react) for 4–6 h. After the reaction, the crude product was dissolved in a suitable amount of dichloromethane, and the reaction solution was slowly added dropwise to 50 mL (ice) of diethyl ether with stirring to precipitate. After washing twice, the product was dried under vacuum at 45 °C to constant weight, yielding a white solid powder.

[0096] The polysarcosine prepared in this comparative example 1 H-NMR spectrum as shown Figure 1 As shown.

[0097] The fluorescence emission spectra of polysarcosine prepared in this comparative example at different excitation wavelengths are as follows: Figure 2 As shown. Photophysical properties: The maximum emission wavelength in solid state is 440 nm, the quantum yield is less than 1.0%, and it emits weak blue light.

[0098] Example 1

[0099] Before the polymerization reaction, a 10 mL thick-walled pressure-resistant tube was dehydrated at 110 °C for 4 hours and then cooled to room temperature in a glove box. Sarcosine-N-carboxycyclic anhydride (138 mg, 1.20 mmol), commercially available triphenylphosphine (7.9 mg, 0.03 mmol), triethylboron (30 μL, 0.03 mmol, 1.0 M THF solution), propylene oxide (30 μL, 0.43 mmol), and anhydrous acetonitrile (0.3 mL) were added sequentially to the tube. The reaction tube was sealed, removed from the glove box, and placed in a 60 °C oil bath under autogenous pressure for 24 h. After the reaction, the tube was cooled to room temperature, and the crude product was dissolved in an appropriate amount of dichloromethane. The reaction solution was slowly added dropwise to 50 mL (ice-cold) diethyl ether with stirring to precipitate the product. After washing twice, the product was dried under vacuum at 45 °C to constant weight to obtain a solid powder.

[0100] The polysarcosine prepared in this embodiment 1 H-NMR spectrum and mass spectra, such as Figures 3-4 As shown, the main chain of the product is dominated by polysarcosine segments and contains a small amount of propylene oxide ring-opening units. The specific structural formula is as follows:

[0101]

[0102] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 5As shown, the optical physical properties of solid-state devices are as follows: the maximum emission wavelength of solid-state devices (λ) em The wavelength of the light emitted is 540 nm, the quantum yield (QY) is 2.8%, and it emits green light. Compared to the polysarcosine prepared in Comparative Example 1, the emission wavelength of this example is redshifted by approximately 100 nm.

[0103] Example 2

[0104] The preparation process is basically the same as in Example 1, with the only difference being:

[0105] Replace triphenylphosphine with an equimolar amount of commercially available tris(4-fluorophenyl)phosphine (9.5 mg, 0.03 mmol).

[0106] The structural formula of polysarcosine prepared in this embodiment is as follows:

[0107]

[0108] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 6 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0109] Example 3

[0110] The preparation process is basically the same as in Example 1, with the only difference being:

[0111] Replace triphenylphosphine with an equimolar amount of commercially available (4-dimethylamino)phenyldiphenylphosphine (9.2 mg, 0.03 mmol).

[0112] The structural formula of polysarcosine prepared in this embodiment is as follows:

[0113]

[0114] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 7 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0115] Example 4

[0116] The preparation process is basically the same as in Example 1, with the only difference being:

[0117] Replace triphenylphosphine with an equimolar amount of commercially available tris(4-methoxyphenyl)phosphine (10.6 mg, 0.03 mmol).

[0118] The structural formula of polysarcosine prepared in this embodiment is as follows:

[0119]

[0120] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 8 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0121] Example 5

[0122] The preparation process is basically the same as in Example 1, with the only difference being:

[0123] Replace triphenylphosphine with an equimolar amount of commercially available 2-(diphenylphosphine)benzaldehyde (8.7 mg, 0.03 mmol).

[0124] The structural formula of polysarcosine prepared in this embodiment is as follows:

[0125]

[0126] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 9 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0127] Example 6

[0128] The preparation process is basically the same as in Example 1, with the only difference being:

[0129] Replace triphenylphosphine with an equimolar amount of commercially available 2-(diphenylphosphine)benzonitrile (8.6 mg, 0.03 mmol).

[0130] The structural formula of polysarcosine prepared in this embodiment is as follows:

[0131]

[0132] The fluorescence emission spectra of polysarcosine prepared in this embodiment at different excitation wavelengths are as follows: Figure 10 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0133] Comparative Example 2

[0134] The preparation process is basically the same as in Example 1, with the only difference being:

[0135] When triphenylphosphine was replaced with an equimolar amount of tris(pentafluorophenyl)phosphine, it was found that the polymerization reaction could not occur.

[0136] Comparative Example 3

[0137] The preparation process is basically the same as in Example 1, with the only difference being:

[0138] When triphenylphosphine was replaced with an equimolar amount of tri(3-sulfonylphenyl)phosphine, it was found that no polymerization reaction could occur.

[0139] Example 7

[0140] The preparation process is basically the same as in Example 6, with the only difference being:

[0141] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of N-ethyl-glycine-N-carboxy ring anhydride.

[0142] The structural formula of poly(N-ethylglycine) prepared in this embodiment is as follows:

[0143]

[0144] The fluorescence emission spectra of poly(N-ethylglycine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 11 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0145] Example 8

[0146] The preparation process is basically the same as in Example 6, with the only difference being:

[0147] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of L-proline-N-carboxy ring anhydride.

[0148] The structural formula of the poly(L-proline) prepared in this embodiment is as follows:

[0149]

[0150] The fluorescence emission spectra of poly(L-proline) prepared in this embodiment at different excitation wavelengths are as follows: Figure 12 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0151] Example 9

[0152] The preparation process is basically the same as in Example 6, with the only difference being:

[0153] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of 4-oxo-L-proline-N-carboxy ring anhydride.

[0154] The structural formula of poly(4-oxoL-proline) prepared in this embodiment is as follows:

[0155]

[0156] The fluorescence emission spectra of poly(4-oxoL-proline) prepared in this embodiment at different excitation wavelengths are as follows: Figure 13 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0157] Example 10

[0158] The preparation process is basically the same as in Example 6, with the only difference being:

[0159] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of L-alanine-N-carboxy ring anhydride.

[0160] The structural formula of poly(L-alanine) prepared in this embodiment is as follows:

[0161]

[0162] The fluorescence emission spectra of the poly(L-alanine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 14 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0163] Example 11

[0164] The preparation process is basically the same as in Example 6, with the only difference being:

[0165] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of L-isoleucine-N-carboxy ring anhydride.

[0166] The structural formula of poly(L-isoleucine) prepared in this embodiment is as follows:

[0167]

[0168] The fluorescence emission spectra of poly(L-isoleucine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 15 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0169] Example 12

[0170] The preparation process is basically the same as in Example 6, with the only difference being:

[0171] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of N-methyl-L-alanine-N-carboxy ring anhydride.

[0172] The structural formula of poly(N-methyl-L-alanine) prepared in this embodiment is as follows:

[0173]

[0174] The fluorescence emission spectra of poly(N-methyl-L-alanine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 16 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0175] Example 13

[0176] The preparation process is basically the same as in Example 6, with the only difference being:

[0177] Replace the sarcosine-N-carboxy ring anhydride with an equimolar amount of N-methyl-L-valine-N-carboxy ring anhydride.

[0178] The structural formula of poly(N-methyl-L-valine) prepared in this embodiment is as follows:

[0179]

[0180] The fluorescence emission spectra of poly(N-methyl-L-valine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 17 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0181] Example 14

[0182] The preparation process is basically the same as in Example 6, with the only difference being:

[0183] Replace the sarcosine-N-carboxycyclic anhydride with an equimolar amount of N-methyl-L-leucine-N-carboxycyclic anhydride.

[0184] The structural formula of poly(N-methyl-L-leucine) prepared in this embodiment is as follows:

[0185]

[0186] The fluorescence emission spectra of poly(N-methyl-L-leucine) prepared in this embodiment at different excitation wavelengths are as follows: Figure 18 As shown; solid-state photophysical performance data are listed in Table 1 below.

[0187] Table 1

[0188]

[0189] It should be noted that the above embodiments are only used to illustrate the present invention, but the present invention is not limited to the above embodiments. Any simple modifications, equivalent changes and alterations made to the above embodiments based on the technical essence of the present invention shall fall within the protection scope of the present invention.

Claims

1. An all-optical color cluster-emitting polypeptoid material, characterized in that, The general structural formula is as follows (I): (Ⅰ); In the formula, R1, R2, and R3 are independently selected from phenyl or substituted phenyl groups; In the substituted phenyl group, the substituent is selected from fluorine, chlorine, bromine, trifluoromethyl, methoxy, dimethylamino, cyano, or aldehyde; the substituent is located at the 2, 3, or 4 position of the benzene ring; R4 and R5 are independently selected from hydrogen, C1-C5 straight-chain or branched alkyl groups, but R4 and R5 are not both hydrogen; Alternatively, R4 and R5 are connected to each other and together with the α-carbon atom and nitrogen atom to which they are connected, they form a five-membered nitrogen-containing ring. The connecting group formed by the connection of R4 and R5 is —CH2—CH2—CH2— or —CH2—C(=O)—CH2—. n is selected from natural numbers from 25 to 40, and m is selected from natural numbers from 1 to 5; The polyluminescent peptide material has a maximum emission wavelength of 495–650 nm in the solid state.

2. The all-color cluster luminescent peptide material according to claim 1, characterized in that: R4 is selected from hydrogen, methyl, ethyl, —CH2—CH2—CH3, —CH(CH3)—CH3—CH(CH3)—CH2—CH3 or —CH2—CH(CH3)—CH3; R5 is selected from hydrogen, methyl, ethyl, —CH2—CH2—CH3, or —CH2—CH2—CH2—CH2—CH3; The quantum yield of the polyluminescent peptide material ranges from <1.0% to 21.4%.

3. The all-optical color cluster-emitting polypeptoid material of claim 1, wherein, The structural formulas are shown in equations (1) to (14) below: (1); (2); (3); (4); (5); (6); (7); (8); (9); (10); (11); (12); (13); (14)。 4. A method for preparing a polyluminescent cluster luminescent peptide material according to any one of claims 1 to 3, characterized in that, include: The all-color cluster luminescent peptide material was prepared by using an organic Lewis acid-base pair composed of a phosphine initiator and triethylboron, and using propylene oxide as a co-initiator to catalyze the ring-opening polymerization of N-carboxylated intracyclic anhydride monomers. The phosphine initiator is selected from triphenylphosphine and / or triphenylphosphine derivatives; The N-carboxyl ring anhydride monomer has the following general structural formula (II): (Ⅱ); In formula (II), R4 and R5 are independently selected from hydrogen, C1-C5 straight-chain or branched alkyl groups, but R4 and R5 are not both hydrogen; Alternatively, R4 and R5 can be linked together to form a five-membered nitrogen-containing ring with the α-carbon atom and nitrogen atom to which they are linked. The linking group formed by the linking of R4 and R5 is —CH2—CH2—CH2— or —CH2—C(=O)—CH2—.

5. The method for preparing the all-color cluster luminescent peptide material according to claim 4, characterized in that: The phosphine initiator is selected from one or more of the following: triphenylphosphine, tris(2-fluorophenyl)phosphine, tris(3-fluorophenyl)phosphine, tris(4-fluorophenyl)phosphine, tris(3-chlorophenyl)phosphine, tris(4-chlorophenyl)phosphine, tris(4-bromophenyl)phosphine, tris(4-trifluoromethylphenyl)phosphine, tris(2-methoxyphenyl)phosphine, tris(3-methoxyphenyl)phosphine, tris(4-methoxyphenyl)phosphine, (4-dimethylamino)phenyldiphenylphosphine, 2-(diphenylphosphine)benzonitrile, 3-(diphenylphosphine)benzonitrile, 4-(diphenylphosphine)benzonitrile, 2-(diphenylphosphine)benzaldehyde, 3-(diphenylphosphine)benzaldehyde, and 4-(diphenylphosphine)benzaldehyde; The N-carboxylate intracyclic anhydride monomer is selected from sarcosine-N-carboxylate intracyclic anhydride, N-ethyl-glycine-N-carboxylate intracyclic anhydride, N-propyl-glycine-N-carboxylate intracyclic anhydride, N-pentyl-glycine-N-carboxylate intracyclic anhydride, L-proline-N-carboxylate intracyclic anhydride, 4-oxo-L-proline-N-carboxylate intracyclic anhydride, L-alanine-N-carboxylate intracyclic anhydride, L-valine-N-carboxylate intracyclic anhydride, and L-leucine-N-carboxylate intracyclic anhydride. One or more of the following: N-carboxylic acid anhydride, L-isoleucine-N-carboxylic acid anhydride, N-methyl-L-alanine-N-carboxylic acid anhydride, N-methyl-L-2-aminobutyric acid-N-carboxylic acid anhydride, N-methyl-L-2-aminovaleric acid-N-carboxylic acid anhydride, N-methyl-L-valine-N-carboxylic acid anhydride, N-methyl-L-leucine-N-carboxylic acid anhydride, and N-methyl-L-isoleucine-N-carboxylic acid anhydride.

6. The method for preparing the all-color cluster luminescent peptide material according to claim 4, characterized in that: The molar ratio of phosphine initiator, triethylboron and N-carboxylate anhydride monomer is 1:(1~3):(20~40). The ring-opening polymerization is carried out at a temperature of 60~80℃ for 12~24h.

7. The method for preparing the all-color cluster luminescent peptide material according to any one of claims 4 to 6, characterized in that: The phosphine initiator is selected from one or more of 2-(diphenylphosphine)benzonitrile, 3-(diphenylphosphine)benzonitrile, 4-(diphenylphosphine)benzonitrile, 2-(diphenylphosphine)benzaldehyde, 3-(diphenylphosphine)benzaldehyde, and 4-(diphenylphosphine)benzaldehyde; The N-carboxycyclic anhydride monomer is selected from one or more of the following: sarcosine-N-carboxycyclic anhydride, N-ethyl-glycine-N-carboxycyclic anhydride, N-propyl-glycine-N-carboxycyclic anhydride, N-pentyl-glycine-N-carboxycyclic anhydride, L-proline-N-carboxycyclic anhydride, 4-oxo-L-proline-N-carboxycyclic anhydride, N-methyl-L-alanine-N-carboxycyclic anhydride, N-methyl-L-2-aminobutyric acid-N-carboxycyclic anhydride, N-methyl-L-2-aminovaleric acid-N-carboxycyclic anhydride, N-methyl-L-valine-N-carboxycyclic anhydride, N-methyl-L-leucine-N-carboxycyclic anhydride, and N-methyl-L-isoleucine-N-carboxycyclic anhydride.

8. The method for preparing the all-color cluster luminescent peptide material according to claim 7, characterized in that, The N-carboxycyclic anhydride monomer is selected from one or more of sarcosine-N-carboxycyclic anhydride, N-ethyl-glycine-N-carboxycyclic anhydride, and L-proline-N-carboxycyclic anhydride.

9. The application of the all-color cluster luminescent peptide material according to any one of claims 1 to 3 in the preparation of luminescent materials, fluorescent labeling materials or fluorescent probes.

10. The application of a polyluminescent cluster luminescent peptide material according to any one of claims 1 to 3 in bioimaging.